Go Pro

Cycurion (CYCU) Financials

Cycurion logo
$0.83 -0.09 (-9.29%)
Closing price 04:00 PM Eastern
Extended Trading
$0.78 -0.05 (-5.78%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Cycurion

Annual Income Statements for Cycurion

This table shows Cycurion's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-0.70 -2.10 1.23 -24
Consolidated Net Income / (Loss)
-0.70 -2.10 1.23 -24
Net Income / (Loss) Continuing Operations
-0.70 -2.10 1.23 -24
Total Pre-Tax Income
-0.45 -2.09 1.23 -24
Total Operating Income
-2.02 0.33 2.42 -23
Total Gross Profit
0.00 2.64 3.63 1.61
Total Revenue
0.00 19 18 15
Operating Revenue
- 19 18 15
Total Cost of Revenue
0.00 17 14 14
Operating Cost of Revenue
- 17 14 14
Total Operating Expenses
2.02 2.32 1.22 25
Selling, General & Admin Expense
1.85 2.32 1.21 9.26
Other Operating Expenses / (Income)
0.16 - 0.01 3.90
Restructuring Charge
- - 0.00 12
Total Other Income / (Expense), net
1.57 -2.42 -1.19 -0.64
Interest Expense
- 2.07 1.21 0.54
Interest & Investment Income
1.57 0.00 0.02 0.03
Other Income / (Expense), net
0.00 -0.35 0.00 -0.13
Income Tax Expense
0.25 0.00 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - 0.00 -0.39
Basic Earnings per Share
($0.10) ($0.14) $4.35 ($13.44)
Weighted Average Basic Shares Outstanding
14.30M 14.78M 282.44K 1.76M
Diluted Earnings per Share
($0.10) ($0.14) $1.66 ($13.39)
Weighted Average Diluted Shares Outstanding
14.30M 14.78M 904.93K 1.76M
Weighted Average Basic & Diluted Shares Outstanding
4.02M - - 5.51M

Quarterly Income Statements for Cycurion

This table shows Cycurion's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-0.25 -1.34 -0.31 0.31 0.12 1.12 -10 -5.29 -3.12 -5.00 -2.13
Consolidated Net Income / (Loss)
-0.25 -1.34 -0.31 0.31 0.12 1.12 -10 -5.29 -3.24 -5.28 -2.56
Net Income / (Loss) Continuing Operations
-0.25 -1.34 -0.31 0.31 0.12 1.12 -10 -5.29 -3.24 -5.28 -2.56
Total Pre-Tax Income
-0.24 -1.40 -0.31 0.31 0.12 1.12 -10 -5.29 -3.24 -5.28 -2.56
Total Operating Income
-0.25 1.14 -0.03 0.73 0.42 1.30 -10 -3.77 -4.53 -5.02 -2.37
Total Gross Profit
0.00 2.64 0.35 1.02 0.72 1.55 0.68 0.24 0.27 0.43 0.69
Total Revenue
0.00 19 4.24 5.00 4.45 4.08 3.87 3.89 3.83 3.54 3.27
Operating Revenue
- - 4.24 5.00 4.45 4.08 3.87 3.89 3.83 3.54 3.27
Total Cost of Revenue
0.00 17 3.90 3.98 3.73 2.53 3.19 3.65 3.56 3.11 2.58
Operating Cost of Revenue
- - 3.90 3.98 3.73 2.53 3.19 3.65 3.56 3.11 2.58
Total Operating Expenses
0.25 1.50 0.38 0.29 0.30 0.25 11 4.00 4.80 5.45 3.06
Selling, General & Admin Expense
0.25 - 0.38 0.29 0.30 0.24 0.34 4.00 2.72 -8.24 2.74
Other Operating Expenses / (Income)
-0.00 - - - 0.00 - 0.00 - 2.08 - 0.32
Restructuring Charge
- - - - 0.00 - 10 - 0.00 - 0.00
Total Other Income / (Expense), net
0.00 -2.54 -0.28 -0.42 -0.30 -0.18 -0.15 -1.52 1.29 -0.26 -0.19
Interest Expense
- - 0.23 0.48 0.32 0.18 0.04 1.52 -1.30 0.29 0.20
Interest & Investment Income
0.05 -0.33 - 0.02 0.00 - 0.00 0.00 0.00 - 0.01
Other Income / (Expense), net
-0.05 -0.13 -0.05 0.04 0.02 -0.00 -0.11 -0.00 -0.01 -0.00 0.00
Income Tax Expense
0.01 -0.06 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - 0.00 - 0.00 - -0.12 - -0.43
Basic Earnings per Share
($0.14) $0.22 ($0.02) $0.02 $0.23 $3.97 ($15.57) ($0.15) ($1.59) ($2.84) ($0.47)
Weighted Average Basic Shares Outstanding
3.61M 14.78M 14.86M 14.97M 498.94K 282.44K 658.22K 34.79M 1.97M 1.76M 4.56M
Diluted Earnings per Share
($0.14) $0.22 ($0.02) $0.01 $0.11 $3.97 ($7.40) ($0.15) ($1.59) ($2.84) ($0.47)
Weighted Average Diluted Shares Outstanding
3.61M 14.78M 14.86M 32.38M 1.12M 904.93K 1.38M 34.89M 1.97M 1.76M 4.56M
Weighted Average Basic & Diluted Shares Outstanding
3.56M 0.00 - - 3.42M 0.00 31.44M 51.43M 2.71M 5.51M 8.59M

Annual Cash Flow Statements for Cycurion

This table details how cash moves in and out of Cycurion's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
0.81 0.51 -0.57 5.21
Net Cash From Operating Activities
-1.32 -1.99 -1.37 -12
Net Cash From Continuing Operating Activities
-1.32 -1.99 -1.37 -12
Net Income / (Loss) Continuing Operations
-0.70 -2.10 1.23 -24
Consolidated Net Income / (Loss)
-0.70 -2.10 1.23 -24
Depreciation Expense
- 0.03 0.01 0.02
Amortization Expense
- 1.09 0.02 0.27
Non-Cash Adjustments To Reconcile Net Income
-1.57 0.32 0.01 12
Changes in Operating Assets and Liabilities, net
0.95 -1.33 -2.65 -0.61
Net Cash From Investing Activities
-116 -0.71 -0.89 1.41
Net Cash From Continuing Investing Activities
-116 -0.71 -0.89 1.41
Purchase of Property, Plant & Equipment
- -0.51 -0.45 -0.46
Divestitures
- 0.00 0.00 0.03
Other Investing Activities, net
-116 -0.20 -0.44 1.83
Net Cash From Financing Activities
118 3.21 1.69 16
Net Cash From Continuing Financing Activities
118 3.21 1.69 16
Repayment of Debt
-0.08 -0.22 0.00 -1.43
Repurchase of Common Equity
-0.43 - 0.00 -1.00
Issuance of Debt
0.00 1.43 0.69 2.89
Issuance of Common Equity
118 2.00 1.00 15

Quarterly Cash Flow Statements for Cycurion

This table details how cash moves in and out of Cycurion's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
0.04 1.02 -0.40 -0.01 -0.12 -0.03 2.23 -1.26 2.64 1.60 -3.23
Net Cash From Operating Activities
-0.16 -1.34 -0.27 -0.58 -0.32 -0.21 -2.75 -3.56 -2.47 -3.31 -2.89
Net Cash From Continuing Operating Activities
-0.16 -1.34 -0.27 -0.58 -0.32 -0.21 -2.75 -3.56 -2.47 -3.31 -2.89
Net Income / (Loss) Continuing Operations
-0.25 -1.34 -0.31 0.31 0.12 1.12 -10 -5.29 -3.24 -5.28 -2.56
Consolidated Net Income / (Loss)
-0.25 -1.34 -0.31 0.31 0.12 1.12 -10 -5.29 -3.24 -5.28 -2.56
Depreciation Expense
- - 0.00 0.00 0.00 0.01 0.00 0.00 0.02 - 0.00
Amortization Expense
- - 0.00 - - 0.02 0.07 0.16 0.03 0.01 0.00
Non-Cash Adjustments To Reconcile Net Income
-0.00 0.44 0.01 - - - 9.21 2.19 0.06 0.83 0.32
Changes in Operating Assets and Liabilities, net
0.10 -1.56 0.03 -0.89 -0.43 -1.36 -1.78 -0.62 0.66 1.13 -0.65
Net Cash From Investing Activities
4.89 -115 -0.11 -0.49 -0.11 -0.19 1.80 -0.10 -0.09 -0.19 -0.13
Net Cash From Continuing Investing Activities
4.89 -115 -0.11 -0.49 -0.11 -0.19 1.80 -0.10 -0.09 -0.19 -0.13
Purchase of Property, Plant & Equipment
- - -0.11 -0.13 -0.11 -0.10 -0.07 -0.10 -0.09 -0.19 -0.13
Acquisitions
- - - - - - 0.03 - - - 0.00
Other Investing Activities, net
4.89 -114 0.00 -0.35 - -0.09 1.83 - - - 0.00
Net Cash From Financing Activities
-4.69 117 -0.02 1.06 0.30 0.36 3.17 2.41 5.20 5.10 -0.21
Net Cash From Continuing Financing Activities
-4.69 117 -0.02 1.06 0.30 0.36 3.17 2.41 5.20 5.10 -0.21
Repayment of Debt
- - -0.01 - - 0.01 -0.03 -0.21 -0.39 -0.80 -0.21
Repurchase of Common Equity
-4.89 - - - - - -1.00 - - - 0.00
Issuance of Debt
- 1.43 -0.02 0.06 0.30 0.35 0.90 0.01 2.36 0.02 0.00
Issuance of Common Equity
- - 0.00 1.00 - - 3.31 0.62 6.61 5.89 0.00

Annual Balance Sheets for Cycurion

This table presents Cycurion's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
0.33 118 21 26 33
Total Current Assets
0.00 1.08 8.41 11 8.00
Cash & Equivalents
0.00 0.81 0.61 0.04 5.26
Accounts Receivable
- 0.00 7.55 11 2.69
Prepaid Expenses
0.00 0.27 0.06 0.10 0.06
Plant, Property, & Equipment, net
0.00 0.00 0.03 0.02 0.00
Total Noncurrent Assets
0.32 117 12 15 25
Goodwill
- - 6.59 6.59 21
Intangible Assets
- - 0.04 4.18 4.61
Total Liabilities & Shareholders' Equity
0.33 118 21 26 33
Total Liabilities
0.31 1.24 16 20 17
Total Current Liabilities
0.31 1.24 14 19 17
Short-Term Debt
0.08 0.00 5.55 7.36 3.13
Accounts Payable
0.01 0.83 2.07 1.68 1.31
Accrued Expenses
0.23 - 2.16 2.93 4.23
Current Employee Benefit Liabilities
- - - 0.98 0.92
Other Taxes Payable
- 0.00 0.00 1.16 1.17
Other Current Liabilities
0.00 0.16 4.08 3.04 4.80
Other Current Nonoperating Liabilities
- - - 1.59 1.35
Total Noncurrent Liabilities
0.00 0.00 1.44 1.44 0.30
Long-Term Debt
- - 0.15 0.15 0.30
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
0.01 -0.26 5.25 3.47 16
Total Preferred & Common Equity
0.01 -0.26 5.25 3.47 20
Preferred Stock
0.00 0.00 0.00 0.00 0.00
Total Common Equity
0.01 -0.26 5.25 3.47 20
Common Stock
0.03 1.61 9.68 6.67 47
Retained Earnings
-0.01 -1.86 -4.43 -3.20 -27
Noncontrolling Interest
- - - 0.00 -3.86

Quarterly Balance Sheets for Cycurion

This table presents Cycurion's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
3.66 3.08 2.75 2.91 32 31 32 31
Total Current Assets
0.41 0.11 0.15 0.31 6.72 5.59 7.04 5.47
Cash & Equivalents
0.30 0.00 0.00 - 2.27 1.01 3.65 2.03
Accounts Receivable
- 0.11 0.09 0.06 4.34 4.52 3.33 3.34
Prepaid Expenses
0.10 0.00 0.04 0.02 0.11 0.05 0.06 0.11
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.02 0.02 0.00 0.00
Total Noncurrent Assets
3.25 2.97 2.60 2.60 25 25 25 26
Goodwill
- - - - 21 21 21 21
Intangible Assets
- - - - 0.02 0.01 0.00 4.74
Total Liabilities & Shareholders' Equity
3.66 3.08 2.75 2.91 32 31 32 31
Total Liabilities
3.28 2.89 3.44 3.98 22 20 17 18
Total Current Liabilities
2.61 2.76 3.33 3.90 22 20 17 17
Short-Term Debt
0.20 0.31 0.57 0.81 7.15 6.53 6.17 2.92
Accounts Payable
0.95 1.22 1.60 1.85 5.67 5.09 2.51 1.44
Accrued Expenses
- - - - 4.23 3.85 4.05 4.28
Current Employee Benefit Liabilities
- - - - - - - 1.31
Other Taxes Payable
1.14 1.15 1.15 1.15 1.17 1.17 1.17 1.17
Other Current Liabilities
- - - 0.08 3.62 3.36 2.71 4.86
Other Current Nonoperating Liabilities
- - - - - - - 1.49
Total Noncurrent Liabilities
0.66 0.13 0.11 0.08 0.30 0.30 0.30 0.30
Long-Term Debt
- - - - 0.30 0.30 0.30 0.30
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-2.89 -2.78 -3.37 -3.74 9.40 10 15 14
Total Preferred & Common Equity
-2.89 -2.78 -3.37 -3.74 13 14 19 18
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-2.89 -2.78 -3.37 -3.74 13 14 19 18
Common Stock
0.00 0.00 0.12 0.12 26 33 41 47
Retained Earnings
-2.89 -2.78 -3.49 -3.86 -13 -19 -22 -29
Noncontrolling Interest
- - - - -3.46 -3.57 -3.68 -4.29

Annual Metrics And Ratios for Cycurion

This table displays calculated financial ratios and metrics derived from Cycurion's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
14,751,000.00 3,556,410.00 3,424,879.00 2,712,489.00
DEI Adjusted Shares Outstanding
491,700.00 118,547.00 114,163.00 2,712,489.00
DEI Earnings Per Adjusted Shares Outstanding
-1.43 -17.69 10.77 -8.72
Growth Metrics
- - - -
Revenue Growth
0.00% 0.00% -8.16% -14.84%
EBITDA Growth
0.00% 154.59% 123.06% -1,047.15%
EBIT Growth
0.00% 99.05% 12,739.87% -1,073.36%
NOPAT Growth
0.00% 116.19% 957.44% -778.38%
Net Income Growth
0.00% -199.18% 158.64% -2,056.66%
EPS Growth
0.00% -40.00% 158.64% -906.63%
Operating Cash Flow Growth
0.00% -50.77% 31.01% -781.39%
Free Cash Flow Firm Growth
0.00% 0.00% -101.59% -952.12%
Invested Capital Growth
0.00% -91.11% 39.65% 9.17%
Revenue Q/Q Growth
0.00% 0.00% -46.22% -3.41%
EBITDA Q/Q Growth
0.00% 176.54% 15.36% -37.46%
EBIT Q/Q Growth
0.00% 98.67% 13.64% -36.66%
NOPAT Q/Q Growth
0.00% 126.63% 53.10% -36.97%
Net Income Q/Q Growth
0.00% -447.46% 200.01% -36.24%
EPS Q/Q Growth
0.00% 53.33% 200.01% -49.94%
Operating Cash Flow Q/Q Growth
0.00% -137.17% 45.29% -34.63%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% -177.84% 41.90%
Invested Capital Q/Q Growth
0.00% 3,566.14% 4,867.79% -13.48%
Profitability Metrics
- - - -
Gross Margin
0.00% 13.66% 20.45% 10.65%
EBITDA Margin
0.00% 5.69% 13.82% -153.68%
Operating Margin
0.00% 1.69% 13.60% -154.72%
EBIT Margin
0.00% -0.10% 13.61% -155.58%
Profit (Net Income) Margin
0.00% -10.84% 6.92% -158.98%
Tax Burden Percent
155.70% 100.18% 100.00% 100.00%
Interest Burden Percent
22.32% 10,938.11% 50.83% 102.19%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.36% 19.50% -108.54%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -108.23% 2.73% -287.46%
Return on Net Nonoperating Assets (RNNOA)
0.00% -3.79% 3.63% -113.93%
Return on Equity (ROE)
-1.20% -3.43% 23.13% -222.48%
Cash Return on Invested Capital (CROIC)
0.00% 167.69% -13.59% -117.31%
Operating Return on Assets (OROA)
0.00% -0.03% 10.44% -79.79%
Return on Assets (ROA)
0.00% -3.02% 5.30% -81.54%
Return on Common Equity (ROCE)
0.00% -0.14% 18.96% -242.43%
Return on Equity Simple (ROE_SIMPLE)
273.39% -39.97% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-1.41 0.23 2.42 -16
NOPAT Margin
0.00% 1.18% 13.60% -108.30%
Net Nonoperating Expense Percent (NNEP)
87.80% 108.59% 16.77% 178.92%
Return On Investment Capital (ROIC_SIMPLE)
- 2.09% 22.02% -83.33%
Cost of Revenue to Revenue
0.00% 86.34% 79.55% 89.35%
SG&A Expenses to Revenue
0.00% 11.97% 6.80% 61.18%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 11.97% 6.86% 165.37%
Earnings before Interest and Taxes (EBIT)
-2.02 -0.02 2.42 -24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-2.02 1.10 2.46 -23
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 7.36 10.35 0.37
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 2.00 2.02 0.49
Price to Earnings (P/E)
0.00 0.00 29.19 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 3.43% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.47 4.23 3.14 0.11
Enterprise Value to Revenue (EV/Rev)
0.00 2.26 2.55 0.12
Enterprise Value to EBITDA (EV/EBITDA)
0.00 39.71 18.44 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 18.72 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 191.32 18.74 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.41 0.00 0.00
Leverage & Solvency
- - - -
Debt to Equity
0.00 1.09 1.39 0.21
Long-Term Debt to Equity
0.00 0.03 0.03 0.02
Financial Leverage
-0.01 0.04 1.33 0.40
Leverage Ratio
1.01 1.14 4.36 2.73
Compound Leverage Factor
0.23 124.40 2.22 2.79
Debt to Total Capital
0.00% 52.08% 58.22% 17.42%
Short-Term Debt to Total Capital
0.00% 50.73% 57.08% 15.89%
Long-Term Debt to Total Capital
0.00% 1.34% 1.14% 1.53%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
100.22% 0.00% 14.88% -19.61%
Common Equity to Total Capital
-0.22% 47.92% 26.91% 102.19%
Debt to EBITDA
0.00 5.18 3.06 -0.15
Net Debt to EBITDA
0.00 4.63 3.04 0.08
Long-Term Debt to EBITDA
0.00 0.13 0.06 -0.01
Debt to NOPAT
0.00 24.95 3.11 -0.21
Net Debt to NOPAT
0.00 22.29 3.09 0.11
Long-Term Debt to NOPAT
0.00 0.64 0.06 -0.02
Altman Z-Score
82.14 1.79 1.53 -3.05
Noncontrolling Interest Sharing Ratio
100.21% 95.92% 18.03% -8.97%
Liquidity Ratios
- - - -
Current Ratio
0.87 0.60 0.58 0.47
Quick Ratio
0.65 0.59 0.58 0.47
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 106 -1.68 -18
Operating Cash Flow to CapEx
0.00% -392.29% -306.09% -2,656.34%
Free Cash Flow to Firm to Interest Expense
0.00 51.17 -1.39 -32.67
Operating Cash Flow to Interest Expense
0.00 -0.96 -1.13 -22.29
Operating Cash Flow Less CapEx to Interest Expense
0.00 -1.20 -1.50 -23.13
Efficiency Ratios
- - - -
Asset Turnover
0.00 0.28 0.77 0.51
Accounts Receivable Turnover
0.00 0.00 1.94 2.25
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 658.41 0.00
Accounts Payable Turnover
0.00 11.54 7.54 9.02
Days Sales Outstanding (DSO)
0.00 0.00 188.31 162.51
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 31.64 48.39 40.45
Cash Conversion Cycle (CCC)
0.00 -31.64 139.92 122.06
Capital & Investment Metrics
- - - -
Invested Capital
116 10 14 16
Invested Capital Turnover
0.00 0.31 1.43 1.00
Increase / (Decrease) in Invested Capital
0.00 -106 4.10 1.32
Enterprise Value (EV)
287 44 45 1.80
Market Capitalization
170 39 36 7.49
Book Value per Share
($0.02) $1.48 $1.01 $7.41
Tangible Book Value per Share
($0.02) ($0.39) ($2.13) ($1.97)
Total Capital
117 11 13 20
Total Debt
0.00 5.70 7.50 3.43
Total Long-Term Debt
0.00 0.15 0.15 0.30
Net Debt
-0.81 5.09 7.46 -1.83
Capital Expenditures (CapEx)
0.00 0.51 0.45 0.46
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.98 -0.75 -0.49 -11
Debt-free Net Working Capital (DFNWC)
-0.17 -0.14 -0.45 -5.78
Net Working Capital (NWC)
-0.17 -5.69 -7.81 -8.91
Net Nonoperating Expense (NNE)
-0.71 2.33 1.19 7.67
Net Nonoperating Obligations (NNO)
-0.81 5.09 9.05 -0.48
Total Depreciation and Amortization (D&A)
0.00 1.12 0.04 0.29
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -3.87% -2.77% -72.92%
Debt-free Net Working Capital to Revenue
0.00% -0.73% -2.54% -38.19%
Net Working Capital to Revenue
0.00% -29.43% -43.94% -58.85%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
($0.10) ($0.50) $2.40 ($13.44)
Adjusted Weighted Average Basic Shares Outstanding
14.30M 4.09M 498.94K 1.76M
Adjusted Diluted Earnings per Share
($0.10) ($0.50) $0.60 ($13.39)
Adjusted Weighted Average Diluted Shares Outstanding
14.30M 4.09M 2.98M 1.76M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
4.02M 0.00 0.00 5.51M
Normalized Net Operating Profit after Tax (NOPAT)
-1.41 0.23 1.69 -8.08
Normalized NOPAT Margin
0.00% 1.18% 9.52% -53.40%
Pre Tax Income Margin
0.00% -10.82% 6.92% -158.98%
Debt Service Ratios
- - - -
EBIT to Interest Expense
0.00 -0.01 2.00 -43.42
NOPAT to Interest Expense
0.00 0.11 2.00 -30.23
EBIT Less CapEx to Interest Expense
0.00 -0.25 1.63 -44.26
NOPAT Less CapEx to Interest Expense
0.00 -0.13 1.63 -31.07
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-61.49% 0.00% 0.00% -4.16%

Quarterly Metrics And Ratios for Cycurion

This table displays calculated financial ratios and metrics derived from Cycurion's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
3,556,410.00 3,556,410.00 3,556,410.00 3,525,267.00 3,497,472.00 3,424,879.00 3,424,879.00 31,443,906.00 51,426,037.00 2,712,489.00 5,509,988.00
DEI Adjusted Shares Outstanding
118,547.00 118,547.00 118,547.00 117,509.00 116,582.00 114,163.00 114,163.00 1,048,130.00 1,714,201.00 2,712,489.00 5,509,988.00
DEI Earnings Per Adjusted Shares Outstanding
-2.14 -11.30 -2.64 2.60 1.00 9.81 -89.77 -5.05 -1.82 -1.84 -0.39
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% -78.93% -8.79% -22.26% -13.87% -13.10% -15.54%
EBITDA Growth
-53.32% 343.13% 75.63% 288.34% 249.88% 31.86% -12,762.91% -568.35% -1,127.44% -478.06% 76.62%
EBIT Growth
-53.32% 343.13% 74.95% 287.80% 249.13% 28.88% -12,506.48% -590.35% -1,143.21% -487.40% 76.78%
NOPAT Growth
-24.58% 376.11% 91.20% 624.37% 342.25% 63.14% -31,197.48% -461.44% -857.38% -370.27% 76.52%
Net Income Growth
-206.95% -457.38% -82.08% 192.05% 145.77% 183.62% -3,179.78% -1,828.36% -2,890.88% -571.49% 75.00%
EPS Growth
-450.00% 266.67% 66.67% 106.25% 145.77% 183.62% -3,179.78% -1,600.00% -2,890.88% -171.54% 93.65%
Operating Cash Flow Growth
-9.19% -600.88% 30.71% -491.24% -102.20% 84.66% -907.58% -515.61% -683.32% -1,511.33% -5.27%
Free Cash Flow Firm Growth
199.49% 0.00% -95.47% -94.40% -99.13% -102.62% -522.08% -407.69% -2,261.53% -72.81% 83.72%
Invested Capital Growth
-99.76% -91.11% -91.12% -102.53% -207.39% 39.65% 2,869.64% 12,180.63% 6,116.15% 9.17% 12.24%
Revenue Q/Q Growth
0.00% 0.00% -78.07% 17.88% -11.01% -8.39% -5.07% 0.46% -1.41% -7.58% -7.74%
EBITDA Q/Q Growth
28.57% 444.12% -107.84% 1,077.67% -43.15% 202.74% -864.50% 64.40% -24.70% -11.40% 52.72%
EBIT Q/Q Growth
28.57% 444.12% -108.06% 1,048.44% -43.28% 197.39% -887.97% 63.11% -20.68% -10.44% 52.77%
NOPAT Q/Q Growth
-24.28% 561.03% -102.83% 3,329.58% -42.58% 210.48% -643.62% 62.70% -20.31% -10.79% 52.77%
Net Income Q/Q Growth
23.73% -428.02% 76.67% 197.96% -62.07% 864.65% -1,015.13% 48.38% 38.76% -62.97% 51.48%
EPS Q/Q Growth
12.50% 257.14% -109.09% 150.00% -62.07% 864.65% -1,015.13% 73.21% 38.76% -78.62% 83.45%
Operating Cash Flow Q/Q Growth
-59.45% -760.32% 79.68% -112.14% 45.47% 34.74% -1,234.55% -29.61% 30.61% -34.25% 12.81%
Free Cash Flow Firm Q/Q Growth
4.88% -7.82% -95.30% 23.40% -83.77% -378.94% -655.54% 10.05% -14.02% 77.70% 28.83%
Invested Capital Q/Q Growth
-94.70% 3,566.14% -95.25% -127.42% -125.05% 4,867.79% 0.94% 11.54% 12.07% -13.48% 3.78%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 13.66% 8.17% 20.48% 16.13% 37.92% 17.51% 6.07% 7.06% 12.09% 21.06%
EBITDA Margin
0.00% 5.20% -1.86% 15.40% 9.84% 32.52% -261.92% -92.81% -117.39% -141.49% -72.51%
Operating Margin
0.00% 5.88% -0.76% 14.58% 9.41% 31.89% -260.91% -96.87% -118.21% -141.71% -72.54%
EBIT Margin
0.00% 5.20% -1.91% 15.36% 9.79% 31.79% -263.85% -96.89% -118.60% -141.71% -72.54%
Profit (Net Income) Margin
0.00% -6.92% -7.36% 6.12% 2.61% 27.47% -264.82% -136.07% -84.53% -149.05% -78.38%
Tax Burden Percent
104.11% 95.64% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
83.38% -139.26% 385.77% 39.84% 26.64% 86.42% 100.36% 140.44% 71.27% 105.18% 108.04%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 1.26% -4.18% 160.84% 0.00% 45.75% -421.86% -136.99% -144.73% -99.41% -47.71%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -98.49% 726.56% -125.41% 0.00% 43.20% -537.90% -220.43% -148.55% -140.62% -70.69%
Return on Net Nonoperating Assets (RNNOA)
0.00% -3.45% -9.46% -7.59% 0.00% 57.48% -307.62% -143.68% -36.97% -55.73% -24.04%
Return on Equity (ROE)
-0.65% -2.19% -13.63% 153.26% 361.11% 103.23% -729.48% -280.67% -181.69% -155.15% -71.76%
Cash Return on Invested Capital (CROIC)
0.00% 167.69% 182.74% 0.00% 0.00% -13.59% -258.05% -153.12% -167.34% -117.31% -82.54%
Operating Return on Assets (OROA)
0.00% 1.45% -7.69% 77.78% 98.43% 24.37% -265.34% -94.24% -105.51% -72.68% -33.48%
Return on Assets (ROA)
0.00% -1.93% -29.68% 30.99% 26.22% 21.06% -266.31% -132.35% -75.20% -76.44% -36.17%
Return on Common Equity (ROCE)
0.02% -0.09% 10.97% -185.50% 3,518.73% 84.62% -767.56% -306.19% -194.41% -169.06% -95.87%
Return on Equity Simple (ROE_SIMPLE)
13.24% 0.00% 80.49% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.17 0.80 -0.02 0.73 0.42 1.30 -7.07 -2.64 -3.17 -3.51 -1.66
NOPAT Margin
0.00% 4.12% -0.53% 14.58% 9.41% 31.89% -182.64% -67.81% -82.75% -99.19% -50.78%
Net Nonoperating Expense Percent (NNEP)
-28.01% 99.75% -730.74% 286.25% 91.71% 2.55% 116.04% 83.44% 3.82% 41.20% 22.98%
Return On Investment Capital (ROIC_SIMPLE)
- 7.28% 0.91% -26.07% -14.26% 11.85% -41.96% -15.26% -14.50% -17.87% -9.82%
Cost of Revenue to Revenue
0.00% 86.34% 91.83% 79.52% 83.87% 62.08% 82.49% 93.93% 92.94% 87.91% 78.94%
SG&A Expenses to Revenue
0.00% 0.00% 8.93% 5.89% 6.72% 5.78% 8.72% 102.93% 70.95% -232.56% 83.94%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 7.78% 8.93% 5.89% 6.72% 6.03% 278.43% 102.93% 125.27% 153.79% 93.60%
Earnings before Interest and Taxes (EBIT)
-0.29 1.01 -0.08 0.77 0.44 1.30 -10 -3.77 -4.55 -5.02 -2.37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.29 1.01 -0.08 0.77 0.44 1.33 -10 -3.61 -4.50 -5.01 -2.37
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 7.36 0.00 0.00 0.00 10.35 0.13 0.78 1.06 0.37 0.31
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 2.00 1.60 1.37 1.12 2.02 0.10 0.67 1.29 0.49 0.38
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 29.19 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 3.43% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
150.61 4.23 83.77 0.00 0.00 3.14 0.23 0.81 1.06 0.11 0.15
Enterprise Value to Revenue (EV/Rev)
0.00 2.26 1.74 1.48 1.23 2.55 0.20 0.81 1.24 0.12 0.17
Enterprise Value to EBITDA (EV/EBITDA)
0.00 39.71 184.16 30.25 19.03 18.44 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 184.16 30.25 19.03 18.72 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 191.32 88.90 38.09 25.67 18.74 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.41 7.48 6.45 18.73 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.53 1.09 1.68 -0.83 -0.76 1.39 0.79 0.65 0.42 0.21 0.24
Long-Term Debt to Equity
0.00 0.03 0.00 0.00 0.00 0.03 0.03 0.03 0.02 0.02 0.02
Financial Leverage
0.00 0.04 -0.01 0.06 -0.97 1.33 0.57 0.65 0.25 0.40 0.34
Leverage Ratio
1.04 1.14 1.92 2.31 -9.65 4.36 3.61 3.43 2.46 2.73 2.73
Compound Leverage Factor
0.86 -1.58 7.41 0.92 -2.57 3.77 3.62 4.82 1.75 2.87 2.95
Debt to Total Capital
34.50% 52.08% 62.62% -475.54% -312.85% 58.22% 44.19% 39.50% 29.54% 17.42% 19.04%
Short-Term Debt to Total Capital
34.50% 50.73% 62.62% -475.54% -312.85% 57.08% 42.44% 37.79% 28.19% 15.89% 17.27%
Long-Term Debt to Total Capital
0.00% 1.34% 0.00% 0.00% 0.00% 1.14% 1.75% 1.71% 1.35% 1.53% 1.78%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
560.40% 0.00% 602.70% -2,237.88% -1,039.42% 14.88% -20.57% -20.65% -16.84% -19.61% -25.39%
Common Equity to Total Capital
-494.90% 47.92% -565.32% 2,813.42% 1,452.27% 26.91% 76.38% 81.15% 87.30% 102.19% 106.35%
Debt to EBITDA
-0.14 5.18 1.38 0.41 0.38 3.06 -0.98 -0.57 -0.38 -0.15 -0.21
Net Debt to EBITDA
0.07 4.63 1.38 0.40 0.36 3.04 -0.68 -0.48 -0.17 0.08 -0.08
Long-Term Debt to EBITDA
0.00 0.13 0.00 0.00 0.00 0.06 -0.04 -0.02 -0.02 -0.01 -0.02
Debt to NOPAT
-0.24 24.95 0.67 0.51 0.51 3.11 -1.39 -0.80 -0.54 -0.21 -0.29
Net Debt to NOPAT
0.12 22.29 0.66 0.50 0.48 3.09 -0.97 -0.68 -0.23 0.11 -0.11
Long-Term Debt to NOPAT
0.00 0.64 0.00 0.00 0.00 0.06 -0.06 -0.03 -0.02 -0.02 -0.03
Altman Z-Score
5.10 1.95 13.14 14.99 14.09 1.39 -1.64 -0.96 -0.56 -1.23 -1.35
Noncontrolling Interest Sharing Ratio
102.35% 95.92% 180.45% 221.04% -874.42% 18.03% -5.22% -9.09% -7.00% -8.97% -33.60%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.16 0.60 0.04 0.04 0.08 0.58 0.31 0.28 0.42 0.47 0.31
Quick Ratio
0.12 0.59 0.04 0.03 0.06 0.58 0.30 0.28 0.42 0.47 0.31
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
116 107 5.01 6.18 1.00 -2.80 -21 -19 -22 -4.84 -3.44
Operating Cash Flow to CapEx
0.00% 0.00% -259.47% -434.56% -300.16% -195.90% -3,921.58% -3,421.17% -2,626.38% -1,772.43% -2,240.18%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 21.65 12.82 3.14 -15.91 -568.03 -12.49 0.00 -16.93 -16.81
Operating Cash Flow to Interest Expense
0.00 0.00 -1.18 -1.20 -0.99 -1.17 -73.72 -2.34 0.00 -11.60 -14.11
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 -1.63 -1.47 -1.31 -1.77 -75.60 -2.40 0.00 -12.26 -14.74
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.28 4.03 5.06 10.05 0.77 1.01 0.97 0.89 0.51 0.46
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 1.94 7.82 7.06 9.24 2.25 3.79
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 658.41 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 11.54 19.08 19.34 20.19 7.54 3.90 3.92 5.93 9.02 3.63
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 188.31 46.66 51.69 39.49 162.51 96.41
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 31.64 19.13 18.88 18.08 48.39 93.54 93.06 61.52 40.45 100.49
Cash Conversion Cycle (CCC)
0.00 -31.64 -19.13 -18.88 -18.08 139.92 -46.88 -41.37 -22.03 122.06 -4.08
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.28 10 0.49 -0.13 -0.30 14 15 16 18 16 16
Invested Capital Turnover
0.00 0.31 7.84 11.03 -3,173.12 1.43 2.31 2.02 1.75 1.00 0.94
Increase / (Decrease) in Invested Capital
-116 -106 -5.03 -5.45 -0.58 4.10 14 16 19 1.32 1.78
Enterprise Value (EV)
42 44 41 42 41 45 3.39 13 19 1.80 2.46
Market Capitalization
39 39 38 39 37 36 1.68 11 20 7.49 5.57
Book Value per Share
($0.81) $1.48 ($0.78) ($0.96) ($1.06) $1.01 $3.76 $0.45 $0.37 $7.41 $6.63
Tangible Book Value per Share
($0.81) ($0.39) ($0.78) ($0.96) ($1.06) ($2.13) ($2.25) ($0.22) ($0.03) ($1.97) ($2.95)
Total Capital
0.58 11 0.49 -0.12 -0.26 13 17 17 22 20 17
Total Debt
0.20 5.70 0.31 0.57 0.81 7.50 7.44 6.82 6.46 3.43 3.22
Total Long-Term Debt
0.00 0.15 0.00 0.00 0.00 0.15 0.30 0.30 0.30 0.30 0.30
Net Debt
-0.10 5.09 0.31 0.55 0.76 7.46 5.17 5.81 2.81 -1.83 1.19
Capital Expenditures (CapEx)
0.00 0.00 0.11 0.13 0.11 0.10 0.07 0.10 0.09 0.19 0.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-2.31 -0.75 -2.34 -2.62 -2.82 -0.49 -10 -8.89 -7.05 -11 -11
Debt-free Net Working Capital (DFNWC)
-2.01 -0.14 -2.34 -2.61 -2.78 -0.45 -7.96 -7.88 -3.40 -5.78 -9.07
Net Working Capital (NWC)
-2.21 -5.69 -2.65 -3.18 -3.58 -7.81 -15 -14 -9.57 -8.91 -12
Net Nonoperating Expense (NNE)
0.08 2.14 0.29 0.42 0.30 0.18 3.18 2.65 0.07 1.77 0.90
Net Nonoperating Obligations (NNO)
-0.10 5.09 0.31 0.55 0.76 9.05 5.17 5.81 2.81 -0.48 2.68
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.00 0.00 0.03 0.07 0.16 0.05 0.01 0.00
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -3.87% -9.93% -9.17% -8.54% -2.77% -58.81% -54.61% -45.02% -72.92% -76.40%
Debt-free Net Working Capital to Revenue
0.00% -0.73% -9.92% -9.12% -8.40% -2.54% -45.76% -48.38% -21.71% -38.19% -62.44%
Net Working Capital to Revenue
0.00% -29.43% -11.23% -11.11% -10.84% -43.94% -86.85% -88.46% -61.06% -58.85% -82.52%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.14) $0.22 $0.12 ($0.20) ($3.30) $119.10 ($16.80) ($0.15) ($1.59) ($2.84) ($0.47)
Adjusted Weighted Average Basic Shares Outstanding
3.61M 14.78M 282.82K 260.52K 8.22K 9.42K 609.05K 34.79M 1.97M 1.76M 4.56M
Adjusted Diluted Earnings per Share
($0.14) $0.22 $0.12 ($0.20) ($3.30) $119.10 ($16.80) ($0.15) ($1.59) ($2.84) ($0.47)
Adjusted Weighted Average Diluted Shares Outstanding
3.61M 14.78M 282.82K 260.52K 8.22K 30.16K 609.05K 34.89M 1.97M 1.76M 4.56M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $119.10 $0.00 $0.00 $0.00 ($2.84) $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
3.56M 0.00 0.00 0.00 114.16K 0.00 1.05M 51.43M 2.71M 5.51M 8.59M
Normalized Net Operating Profit after Tax (NOPAT)
-0.17 0.80 -0.02 0.51 0.29 0.91 0.24 -2.64 -3.17 -3.51 -1.66
Normalized NOPAT Margin
0.00% 4.12% -0.53% 10.21% 6.59% 22.32% 6.16% -67.81% -82.75% -99.19% -50.78%
Pre Tax Income Margin
0.00% -7.24% -7.36% 6.12% 2.61% 27.47% -264.82% -136.07% -84.53% -149.05% -78.38%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 -0.35 1.59 1.36 7.36 -274.22 -2.47 0.00 -17.57 -11.58
NOPAT to Interest Expense
0.00 0.00 -0.10 1.51 1.31 7.39 -189.82 -1.73 0.00 -12.30 -8.10
EBIT Less CapEx to Interest Expense
0.00 0.00 -0.80 1.32 1.03 6.77 -276.10 -2.54 0.00 -18.23 -12.20
NOPAT Less CapEx to Interest Expense
0.00 0.00 -0.55 1.24 0.98 6.79 -191.70 -1.80 0.00 -12.96 -8.73
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-29,847.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -4.16% 0.00%

Financials Breakdown Chart

Key Financial Trends

Cycurion’s Q1 2026 results show some improvement from the severe losses reported earlier in 2025, but the company remains financially strained. Revenue was $3.3 million, down from $3.5 million in Q4 2025 and $3.8 million in Q1 2025. The company posted a net loss of $2.6 million, an improvement from the $5.3 million loss in Q4 2025 and the $10.2 million loss in Q1 2025.

Gross margin improved to approximately 21.1% in Q1 2026, compared with 12.1% in Q4 2025 and 7.1% in Q3 2025. However, selling, general and administrative expenses were $2.7 million, leaving Cycurion with an operating loss of $2.4 million. Interest expense added another $204,852 of pressure.

Cash generation remains the most significant concern. Cycurion used $2.9 million in operating cash during Q1 2026 and ended the quarter with $2.0 million of cash. The company also spent $129,000 on property and equipment and repaid $207,850 of debt, resulting in a total quarterly cash decline of $3.2 million.

  • The net loss narrowed substantially, falling to $2.6 million in Q1 2026 from $10.2 million in Q1 2025 and $5.3 million in Q4 2025.
  • Gross margin recovered to approximately 21.1% in Q1 2026, above the 6% to 12% range reported during Q2 through Q4 2025.
  • Short-term debt declined to $2.9 million in Q1 2026 from $6.5 million in Q2 2025, reflecting continued debt repayments.
  • Accounts receivable remained relatively stable at $3.3 million, while total assets increased to $31.4 million from $30.7 million in Q2 2025.
  • Q1 2026 financing activity was nearly neutral, with only $167,000 of common-stock issuance offsetting $207,850 of debt repayments; this provided little support for the company’s cash position.
  • The financial data includes restated and calculated prior-period figures, and the sharp changes in reported share counts and asset classifications make some year-over-year comparisons less straightforward.
  • Operating cash flow has remained negative in every reported quarter since Q3 2023, including cash usage of $2.9 million in Q1 2026.
  • Revenue has generally declined from $5.0 million in Q2 2024 and $4.1 million in Q4 2024 to $3.3 million in Q1 2026, limiting the company’s ability to absorb fixed expenses.
  • Liquidity is weak: Cycurion had $5.5 million of current assets versus $17.5 million of current liabilities at March 31, 2026, implying a current ratio of approximately 0.31.
  • Goodwill and intangible assets totaled approximately $26.97 million, or about 86% of total assets, creating potential impairment risk if expected business performance does not improve.

Overall, Cycurion’s profitability trend is moving in the right direction from the exceptionally large losses recorded in early 2025, and debt has been reduced. Nevertheless, declining revenue, persistent operating cash burn, substantial current liabilities and a balance sheet heavily dependent on goodwill leave the company reliant on a sustained improvement in operations or additional financing.

08/04/26 09:16 PM ETAI Generated. May Contain Errors.

Cycurion Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cycurion's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Cycurion's net income appears to be on an upward trend, with a most recent value of -$24.06 million in 2025, rising from -$700.93 thousand in 2022. The previous period was $1.23 million in 2024. See where experts think Cycurion is headed by visiting Cycurion's forecast page.

Cycurion's total operating income in 2025 was -$23.41 million, based on the following breakdown:
  • Total Gross Profit: $1.61 million
  • Total Operating Expenses: $25.03 million

Over the last 3 years, Cycurion's total revenue changed from $0.00 in 2022 to $15.13 million in 2025, a change of 1,513,364,700.0%.

Cycurion's total liabilities were at $17.21 million at the end of 2025, a 14.7% decrease from 2024, and a 5,391.0% increase since 2021.

In the past 4 years, Cycurion's cash and equivalents has ranged from $3.91 thousand in 2021 to $5.26 million in 2025, and is currently $5.26 million as of their latest financial filing in 2025.

Over the last 3 years, Cycurion's book value per share changed from -0.02 in 2022 to 7.41 in 2025, a change of -42,689.7%.



Financial statements for NASDAQ:CYCU last updated on 7/30/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners